Evaluation of mast cells and hypoxia inducible factor-1 expression in meningiomas of various grades in correlation with peritumoral brain edema

Journal of Neuro-Oncology

Volumn 115, Issue 1, 2013, Pages 119-125

  Reszec, Joanna ^a   Hermanowicz, Adam ^a   Rutkowski, Robert ^a   Bernaczyk, Piotr ^a   Mariak, Zenon ^a   Chyczewski, Lech ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Hypoxia inducible factor 1; Mast cells; Meningioma

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; TRYPTASE;

ADULT; AGE DISTRIBUTION; ARTICLE; BRAIN EDEMA; BRAIN HYPOXIA; CANCER GRADING; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURGERY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE MARKER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MAST CELL; MENINGIOMA; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERITUMORAL BRAIN EDEMA; PROTEIN EXPRESSION; SEX DIFFERENCE; STEINHOFF CLASSIFICATION;

BIOLOGICAL MARKERS; BRAIN EDEMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MAGNETIC RESONANCE IMAGING; MALE; MAST CELLS; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; TRYPTASES;

EID: 84885469848     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-013-1208-1     Document Type: Article

References (34)

1. Beaven MA (2009) Our perception of the mast cell from Paul Ehrlich to now. Eur J Immunol 39:11-25
2. Vyas H, Krishnaswamy G (2006) Paul ehrlich's Mastzellen-from aniline dyes to DNA chip arrays: a historical review of developments in mast cell research. Methods Mol Biol 315:3-11
3. Rao KN, Brown M (2008) Mast cells: multifaceted immune cells with diverse roles in health and disease. Ann NY Acad Sci 1143:83-104
4. Theoharides TC, Conti P (2004) Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol 25(5):235-241
5. Lennert K, Parwaresch MR (1979) Mast cells and mast cell neoplasia: a review. Histopathology 3:349-365
6. Ribatti D, Crivellato E (2012) Mast cells, angiogenesis, and tumor growth. Biochim Biophys Acta 1822(1):2-8
7. Panula P, Lintunen M, Karlstedt K (2000) Histamine in brain development and tumors. Semin Cancer Biol 10(1):11-14
8. Kaal EC, Vecht CJ (2004) The management of brain edema in brain tumors. Curr Opin Oncol 16(6):593-600
9. Kan P, Liu JK, Wendland MM, Shrieve D, Jensen RL (2007) Peritumoral edema after stereotactic radiosurgery for intracranial meningiomas and molecular factors that predict its development. J Neurooncol 83(1):33-38
10. Lindsberg PJ, Strbian D, Karjalainen-Lindsberg ML (2010) Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage. J Cereb Blood Flow Metab 4:689-702
11. Vignes JR, Sesay M, Rezajooi K, Gimbert E, Liguoro D (2008) Peritumoral edema and prognosis in intracranial meningioma surgery. J Clin Neurosci 15(7):764-768
12. Jensen RL (2009) Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target. J Neurooncol 92(3):317-335
13. Bo L, Mork SJ, Nyland H (1992) An immunohistochemical study of mononuclear cells in meningiomas. Neuropathol Appl Neurobiol 18(6):548-558
14. Tirakotai W, Mennel HD, Celik I, Hellwig D, Bertalanffy H, Riegel T (2006) Secretory meningioma: immunohistochemical findings and evaluation of mast cells infiltration. Neurosurg Rev 29(1):41-48
15. Theoharides TC, Rozniecki JJ, Sahagian G et al (2008) Impact of stress and mast cells on brain metastases. J Neuroimmunol 205(1-2):1-7
16. Kazner E, Lanksch W, Steinhoff H, Wilske J (1975) Computerized axial tomography of the skull - diagnostic possibilities and clinical results. Fortschr Neurol Psychiatr Grenzgeb 43(10):487-574
17. Zhong H, De Marzo AM, Laughner E et al (1999) Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res 59(22):5830-5835
18. Gulliksson M, Carvalho RF, Ullerås E, Nilsson G (2010) Mast cell survival and mediator secretion in response to hypoxia. PLoS ONE 5(8):e12360
19. Imtiyaz HZ, Simon MC (2010) Hypoxia-inducible factors as essential regulators of inflammation. Curr Top Microbiol Immunol 345:105-120
20. Go G, Wilmink JT, Molenaar WM (1988) Peritumoral brain edema associated with meningiomas. Neurosurgery 23(2):175-179
21. Klç T, Bayri Y, Özduman K et al (2002) Tenascin in meningioma: expression is correlated with anaplasia, vascular endothelial growth factor expression, and peritumoral edema but not with tumor border shape. Neurosurgery 51(1):183-194
22. Schmid S, Aboul-Enein F, Pfisterer W, Birkner T, Stadek C, Knosp E (2010) Vascular endothelial growth factor: the major factor for tumor neovascularization and edema formation in meningioma patients. Neurosurgery 67(6):1703-1708
23. Park MW, Kim CH, Cheong JH, Bak KH, Kim JM, Oh SJ (2006) Occludin expression in brain tumors and its relevance to peritumoral edema and survival. Cancer Res Treat 38(3):139-143
24. Papadopoulos MC, Saadoun S, Woodrow CJ, Davies DC, Costa-Martins P, Moss RF, Krishna S, Bell BA (2001) Occludin expression in microvessels of neoplastic and non-neoplastic human brain. Neuropathol Appl Neurobiol 27(5):384-395
25. Davies DC (2002) Blood-brain barrier breakdown in septic encephalopathy and brain tumours. J Anat 200(6):639-646
26. Mattei TA, Mattei JA, Ramina R, Aguiar PH, Plese JP, Marino R Jr (2005) Edema and malignancy in meningiomas. Clinics (Sao Paulo) 60(3):201-206
27. Osawa T, Tosaka M, Nagaishi M, Yoshimoto Y (2013) Factors affecting peritumoral brain edema in meningioma: special histological subtypes with prominently extensive edema. J Neurooncol 111(1):49-57. doi: 10.1007/s11060-012-0989-y
28. Kaynar MY, Sanus GZ, Hnimoglu H et al (2008) Expression of hypoxia inducible factor-1 alpha in tumors of patients with glioblastomamultiforme and transitional meningioma. J Clin Neurosci 15(9):1036-1042
29. Jensen RL, Soleau S, Bhayani MK, Christiansen D (2002) Expression of hypoxia inducible factor-1 alpha and correlation with preoperative embolization of meningiomas. J Neurosurg 97(3):658-667
30. Jensen R, Lee J (2012) Predicting outcomes of patients with intracranial meningiomas using molecular markers of hypoxia, vascularity, and proliferation. Neurosurgery. 71(1):146-156
31. Yoo H, Baia GS, Smith JS et al (2007) Expression of the hypoxia marker carbonic anhydrase 9 is associated with anaplastic phenotypes in meningiomas. Clin Cancer Res 13(1):68-75
32. Spanberger T, Berghoff AS, Dinhof C et al (2012) Extent of peritumoral brain edema correlates with prognosis, tumoral growth pattern, HIF1a expression and angiogenic activity in patients with single brain metastases. Clin Exp Metastasis 30(4):357-368
33. Schober R, Himuro H, Wechsler W (1988) Cystic changes and vascular permeability in meningiomas. Clin Neuropathol 7(1):16-21
34. Popovic EA, Lyons MK, Scheithauer BW, Marsh WR (1994) Mast cell-rich convexity meningioma presenting as chronic subdural hematoma: case report and review of the literature. Surg Neurol 42(1):8-13